Advanced Search

Technical Analysis for FMTX - Forma Therapeutics Holdings, Inc.

Grade Last Price % Change Price Change
grade A 49.5 13.19% 5.77
FMTX closed up 13.19 percent on Friday, September 25, 2020, on 1.47 times normal volume. The bulls were able to push the stock to a new 52-week high.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Up
Historical FMTX trend table...
Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
New 52 Week High Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Above Upper BB Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
20 DMA Support Bullish 13.19%
Older End-of-Day Gignals for FMTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
New 52 Week High 1 day ago
Up 10% 1 day ago
Up 1 ATR 1 day ago
Rose Above Upper Bollinger Band 1 day ago
Upper Bollinger Band Resistance 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators Basic chart:

Profile

Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
Biopharmaceutical Cancers Regulus Therapeutics Pharmaceutical Companies Trubion

Is FMTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Sep 20 We Think Forma Therapeutics Holdings (NASDAQ:FMTX) Can Afford To Drive Business Growth
Sep 15 Forma Therapeutics Appoints Two New Vice Presidents to Lead Key Organizational Functions
Sep 9 Forma Therapeutics Appoints Biopharma Veteran Thomas G. Wiggans to Board of Directors
Aug 13 Forma Therapeutics EPS misses by $3.84
Aug 13 Forma Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update
Jul 30 Forma Therapeutics Elects Distinguished Researcher and Physician Wayne A.I. Frederick, M.D., to Board of Directors
Jul 12 The Week Ahead In Biotech: J&J Kickstarts Pharma Earnings, Repare Therapeutics IPO
Jul 2 Leaf Group, Forma Therapeutics See Activist Action
Jun 26 The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
Jun 23 Forma Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
See more FMTX news...

Indicators

Indicator Value
52 Week High 52.0887
52 Week Low 31.45
Average Volume 202,584
200-Day Moving Average 0.00
50-Day Moving Average 39.34
20-Day Moving Average 43.71
10-Day Moving Average 44.66
Average True Range 4.53
ADX 32.57
+DI 28.51
-DI 10.11
Chandelier Exit (Long, 3 ATRs ) 38.51
Chandelier Exit (Short, 3 ATRs ) 50.11
Upper Bollinger Band 48.09
Lower Bollinger Band 39.33
Percent B (%b) 1.16
BandWidth 20.05
MACD Line 1.58
MACD Signal Line 1.35
MACD Histogram 0.2298
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 63.39
Resistance 3 (R3) 62.71 57.40 61.07
Resistance 2 (R2) 57.40 53.86 57.74 60.30
Resistance 1 (R1) 53.45 51.68 55.42 54.13 59.53
Pivot Point 48.14 48.14 49.13 48.48 48.14
Support 1 (S1) 44.19 44.60 46.17 44.87 39.47
Support 2 (S2) 38.88 42.42 39.22 38.70
Support 3 (S3) 34.93 38.88 37.93
Support 4 (S4) 35.61